Which stock is cheaper: LUPIN or SUNPHARMA?

Based on Price to Earnings, LUPIN trades at a P/E of 16.8 while SUNPHARMA trades at a P/E of 36.1.

Does LUPIN or SUNPHARMA have higher ROCE?

LUPIN generates an ROCE of 31.1% compared to SUNPHARMA's ROCE of 22.1%.

LUPIN LIMITED (LUPIN) has a market cap of ₹95,797 Cr compared to SUN PHARMACEUTICAL IND L (SUNPHARMA) with ₹4,41,478 Cr.

LUPINHealthcare

Leads (4/5)

₹2,011.00+1.06%

Market Cap: ₹95,797 Cr

SUNPHARMAHealthcare

₹1,777.70+0.95%

Market Cap: ₹4,41,478 Cr

Automated quantitative breakdown of fundamental strengths between LUPIN and SUNPHARMA.

Attractive ValuationLUPIN (P/E 16.8)Trades at lower Price-to-Earnings

Capital EfficiencyLUPIN (ROCE 31.1%)Superior operating return on capital

Balance Sheet SafetyLUPINLower debt-to-equity ratio

Shareholder YieldSUNPHARMA (4.84%)Higher annual dividend yield

Green highlight indicates the stronger metric

Financial Metric	LUPIN	SUNPHARMA
Valuation Multiples
Market Capitalization	₹95,797 Cr	₹4,41,478 Cr
Price to Earnings (P/E)	16.83	36.07
Price to Book (P/B)	3.18	19.73
Profitability & Capital Efficiency
Return on Capital Employed (ROCE)	31.14%	22.11%
Return on Equity (ROE)	16.19%	12.96%
Operating Profit Margin (OPM)	26.45%	27.39%
Net Profit Margin (NPM)	33.36%	12.40%
Balance Sheet & Solvency
Debt to Equity Ratio	0.04	0.61
Dividend Yield	4.38%	4.84%
Historical Growth
3-Year Sales Growth (CAGR)	28.20%	11.41%
Latest Quarter Financial Results
Quarterly Revenue (30 Jun 2026)	₹8,217 Cr	₹15,184 Cr
Quarterly Net Profit	₹1,415 Cr	₹2,895 Cr